Search results for #LCSM
Did you know that <40% of eligible #NSCLC patients receive targeted therapy? #LCSM Examine common barriers encountered throughout the #BiomarkerTesting journey and discover solutions that can improve patient access to targeted therapies. Learn more here: e.lilly/3QfQPLV
Join us June 25, for a live virtual expert-led cancer #immunotherapy program, ACI: A Focus on Lung Cancers. This program features a discussion on IO and biomarker-driven lung cancer. Register now: ow.ly/qOoK50RstN7 #NSCLC @IASLC #LCSM @NarjustFlorezMD @LealTiciana
Dr. Upal Basu Roy of @LUNGevity spoke with CURE® about the recent #FDA approval of Alecensa for certain patients with ALK-positive #NSCLC and how this approval led to "landmark" results within the space. #LCSM. Read the article here: curetoday.com/view/-landmark…
Today is the last day for patients and caregivers to share your experiences with biomarker testing for NSCLC. This survey is supported by @IASLC, @LUNGevity, @isliquidbiopsy, @LungCancerEu and the Israeli Lung Cancer Foundation (@ShaniShilo). #LCSM #precisionmedicine #lungcancer
Today is the last day for patients and caregivers to share your experiences with biomarker testing for NSCLC. This survey is supported by @IASLC, @LUNGevity, @isliquidbiopsy, @LungCancerEu and the Israeli Lung Cancer Foundation (@ShaniShilo). #LCSM #precisionmedicine #lungcancer
On this last day of Cancer Prevention & Early Detection Month, let's take a look at @ALLIANCE_org A211901, a smoking cessation study for cancer survivors in rural communities, led by .@noonan_devon @DukeU_NrsngSchl - Visit bit.ly/Alliance-A2119… #NCI #NCORP #LCsm @NCIprevention
During #ELCC24, @JeffBradleyMD presented late-breaking results from the PACIFIC-2 trial. Read a recap in #ILCN: bit.ly/3JDDRUE #LCSM
Don't miss the April #ASCOPlenarySeries session at 3:00 PM ET TODAY! The session will feature findings on glecirasib for the treatment of #NSCLC w/ KRAS G12C Mutation. Tune in here: brnw.ch/21wJkcn #LCSM @MLJohnsonMD2 @StephenVLiu @JuliaRotow
Beautifully conducted/illustrated study on neoadj combo immunotherapy for resectable NSCLC #lcsm friends should read it without any lag! Or with LAG??? Hard to say yet😉
Beautifully conducted/illustrated study on neoadj combo immunotherapy for resectable NSCLC #lcsm friends should read it without any lag! Or with LAG??? Hard to say yet😉 https://t.co/3WjjeDQxib
Yasir Y. Elamin, MD, discussed the intracranial efficacy of brigatinib from the ALTA-1L trial for patients with ALK+ #NSCLC. #lcsm | @MDAndersonNews targetedonc.com/view/intracran…
Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations | JCO Oncology Practice ascopubs.org/doi/full/10.12… #gyncsm #bcsm #lcsm provides guidance for all stake holders -person centered care!
New podcast dropping tomorrow ... watch this space #LCSM
eRACE Lung Cancer starts tomorrow! Log your miles by walking, swimming, running, hiking, or biking to raise lung cancer awareness throughout May. Sign up for free here: lungevity.org/eRACE #lcsm #lungcancerawareness #lungcancerhopemonth #transforminglungcancer